Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
21.60
1.30 (6.40%)
At close: Aug 15, 2025, 2:57 PM
Sarepta Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 2.48B | 2.23B | 1.9B | 1.64B | 1.5B | 1.4B | 1.24B | 1.1B | 1B | 975.68M | 933.01M | 876.05M | 835.18M | 765.79M | 701.89M | 645.56M | 600.08M | 573.36M |
Cost of Revenue | 524.96M | 414.82M | 327.82M | 239.69M | 185.03M | 165.88M | 150.34M | 136.97M | 139.89M | 143.56M | 139.99M | 140.93M | 124.43M | 106.15M | 97.05M | 87.71M | 79.28M | 73.11M |
Gross Profit | 1.96B | 1.82B | 1.57B | 1.4B | 1.32B | 1.24B | 1.09B | 968.02M | 863.54M | 832.12M | 793.02M | 735.11M | 710.76M | 659.64M | 604.84M | 557.86M | 520.8M | 500.25M |
Operating Income | -932K | -117.21M | 218.08M | 81.03M | 37.99M | -94.83M | -267.82M | -399.28M | -509.8M | -587.41M | -536.2M | -535.18M | -438.28M | -394.73M | -459.71M | -524.61M | -627.22M | -598M |
Interest Income | 52.6M | 64.3M | 71.77M | 79.7M | 84.19M | 86.55M | 85.97M | 72.47M | 57.86M | 39.06M | 19.92M | 10.89M | 2.83M | 468K | 354K | 330K | 304K | 890K |
Pretax Income | -24.13M | -164.19M | 260.77M | 129.4M | 62.22M | 34.06M | -520.1M | -661.77M | -885.02M | -1.1B | -689.96M | -710.55M | -502.04M | -355.7M | -418.95M | -485.54M | -634.04M | -703.08M |
Net Income | -57.96M | -248.39M | 235.24M | 121.84M | 47.3M | 16.9M | -535.98M | -690.88M | -907.68M | -1.12B | -703.49M | -716.23M | -506.63M | -356.56M | -418.78M | -486.12M | -634.47M | -703.89M |
Selling & General & Admin | 553.43M | 562.36M | 555.74M | 523.56M | 516.26M | 498.16M | 481.87M | 470.65M | 454.54M | 490.3M | 451.42M | 409M | 365.34M | 283.37M | 282.66M | 290.65M | 304.9M | 306.24M |
Research & Development | 1.4B | 1.37B | 792.49M | 788.06M | 757.88M | 826.06M | 877.39M | 895.67M | 918.08M | 928.52M | 877.09M | 860.58M | 782.99M | 770.28M | 771.18M | 781.13M | 832.45M | 781.35M |
Other Expenses | 1.2M | 1.47M | 195.22M | 195.98M | 194.96M | 194.84M | 670K | 86K | 689K | 714K | 714K | 412K | -80K | -686K | -936K | -136K | -703K | -647K |
Operating Expenses | 1.96B | 1.94B | 1.36B | 1.32B | 1.28B | 1.33B | 1.36B | 1.37B | 1.37B | 1.42B | 1.33B | 1.27B | 1.15B | 1.05B | 1.05B | 1.07B | 1.14B | 1.09B |
Interest Expense | 19.12M | 18.73M | 18.39M | 19.15M | 19.46M | 19.85M | 22.01M | 23.46M | 32.97M | 43.77M | 53.25M | 62.61M | 63.87M | 63.67M | 63.52M | 66.21M | 64.1M | 61.98M |
Selling & Marketing Expenses | 32M | 29.86M | 29.86M | -220.61M | -220.61M | -218.47M | -218.47M | 14.6M | 14.6M | 14.6M | 14.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.48B | 2.35B | 1.68B | 1.56B | 1.47B | 1.5B | 1.51B | 1.5B | 1.51B | 1.56B | 1.47B | 1.41B | 1.27B | 1.16B | 1.15B | 1.16B | 1.22B | 1.16B |
Income Tax Expense | 33.83M | 84.2M | 25.54M | 7.56M | 14.93M | 17.16M | 15.88M | 29.1M | 22.66M | 16.69M | 13.53M | 5.68M | 4.6M | 854K | -168K | 572K | 431K | 805K |
Shares Outstanding (Basic) | 98M | 97.36M | 96.28M | 95.39M | 94.62M | 93.99M | 93.62M | 88.89M | 88.74M | 88.19M | 87.84M | 87.63M | 87.35M | 87.25M | 79.88M | 79.88M | 79.75M | 79.45M |
Shares Outstanding (Diluted) | 106.62M | 97.36M | 108.47M | 100.45M | 94.62M | 99.11M | 105.59M | 88.89M | 88.74M | 88.19M | 87.84M | 87.63M | 87.51M | 87.25M | 79.88M | 79.88M | 79.75M | 79.45M |
EPS (Basic) | -0.59 | -2.53 | 2.45 | 1.29 | 0.48 | 0.14 | -6.1 | -7.83 | -10.31 | -12.69 | -8.03 | -8.32 | -5.98 | -4.35 | -5.25 | -6.13 | -8.03 | -8.94 |
EPS (Diluted) | -0.88 | -2.7 | 2.27 | 1.20 | 0.41 | 0.07 | -6.16 | -7.83 | -10.31 | -12.69 | -8.03 | -8.32 | -5.98 | -4.35 | -5.25 | -6.13 | -8.03 | -8.94 |
EBITDA | 43.97M | -117.73M | 309.62M | 179.91M | 110.33M | 103.33M | -446.85M | -588.19M | -794.66M | -1B | -582.12M | -597.3M | -387.32M | -240.68M | -307.29M | -369.99M | -530.54M | -608.74M |
EBIT | -5.01M | -145.46M | 279.17M | 148.55M | 81.68M | 53.91M | -498.09M | -638.31M | -852.05M | -1.05B | -636.72M | -647.94M | -438.17M | -292.03M | -355.42M | -419.34M | -569.94M | -641.1M |
Depreciation & Amortization | 48.98M | 46.85M | 49.57M | 50.46M | 55.41M | 57.06M | 58.89M | 57.77M | 57.38M | 54.75M | 54.6M | 50.64M | 50.85M | 51.35M | 48.13M | 45.27M | 37.31M | 31.53M |